BRCA1 and breast cancer: While BRCA1 promoter methylation and BRCA1 PVs seem to a large extent to be mutually exclusive in both TNBCs and HGSOCs [7, 12], conflicting evidence indicates similarities and differences between tumors harboring BRCA1 promoter methylation or a PV regarding therapy sensitivity in breast cancer [8, 13, 14].